Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Winder

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|April 19, 1975
Letter: Primary L.C.A.T.-deficiency diseaseA J Bron, J K Lloyd, A S Fosbrooke, et al.
Atherosclerosis|January 22, 2000
More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemiaA S Wierzbicki, M A Crook, D R Nair, et al.
Nephron|January 1, 1990
Receptor-mediated endocytosis of low-density lipoprotein by cultured human glomerular cellsH C Rayner, T Horsburgh, S L Brown, et al.
British Medical Journal (Clinical Research Ed.)|June 18, 1988
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in BritainJ I Mann, B Lewis, J Shepherd, et al.
The British Journal of Ophthalmology|July 1, 1982
Galactose intolerance and the risk of cataractA F Winder, P Fells, R B Jones, et al.
Journal of Clinical Pathology|April 1, 1996
Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic diseaseA F Winder, C Jagger, D P Garrick, et al.
International Angiology : a Journal of the International Union of Angiology|April 16, 1999
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle adviceD P Mikhailidis, E S Ganotakis, K A Spyropoulos, et al.
Journal of Clinical Pathology|August 18, 1999
A first British case of fish-eye disease presenting at age 75 years: a double heterozygote for defined and new mutations affecting LCAT structure and expressionA F Winder, J S Owen, P H Pritchard, et al.
Clinical Science (London, England : 1979)|December 1, 1993
Brisk walking and serum lipoprotein variables in formerly sedentary men aged 42-59 yearsD J Stensel, A E Hardman, K Brooke-Wavell, et al.
Journal of Clinical Pathology|March 29, 2002
Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular riskD J Byrne, I A Jagroop, H E Montgomery, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|April 19, 1975
Letter: Primary L.C.A.T.-deficiency diseaseA J Bron, J K Lloyd, A S Fosbrooke, et al.
Atherosclerosis|January 22, 2000
More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemiaA S Wierzbicki, M A Crook, D R Nair, et al.
Nephron|January 1, 1990
Receptor-mediated endocytosis of low-density lipoprotein by cultured human glomerular cellsH C Rayner, T Horsburgh, S L Brown, et al.
British Medical Journal (Clinical Research Ed.)|June 18, 1988
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in BritainJ I Mann, B Lewis, J Shepherd, et al.
The British Journal of Ophthalmology|July 1, 1982
Galactose intolerance and the risk of cataractA F Winder, P Fells, R B Jones, et al.
Journal of Clinical Pathology|April 1, 1996
Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic diseaseA F Winder, C Jagger, D P Garrick, et al.
International Angiology : a Journal of the International Union of Angiology|April 16, 1999
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle adviceD P Mikhailidis, E S Ganotakis, K A Spyropoulos, et al.
Journal of Clinical Pathology|August 18, 1999
A first British case of fish-eye disease presenting at age 75 years: a double heterozygote for defined and new mutations affecting LCAT structure and expressionA F Winder, J S Owen, P H Pritchard, et al.
Clinical Science (London, England : 1979)|December 1, 1993
Brisk walking and serum lipoprotein variables in formerly sedentary men aged 42-59 yearsD J Stensel, A E Hardman, K Brooke-Wavell, et al.
Journal of Clinical Pathology|March 29, 2002
Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular riskD J Byrne, I A Jagroop, H E Montgomery, et al.
Pageof 10